...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: New docs for Zenith in SEDAR 9/28/16

New docs for Zenith in SEDAR as of 9/28/16: MD&A, Interim Financial Statements/Report.

Share
New Message
Please login to post a reply